Cargando…
Diabetic Nephropathy and Proton Pump Inhibitors – Pilot Case-Control Study
INTRODUCTION: Proton pump inhibitors (PPIs) are liberally used over the counter medication and is largely considered safe. Off late, there are many reports that suggest increased incidence of chronic kidney disease with long-term PPI use. PPIs are often prescribed in patients with diabetes mellitus...
Autores principales: | Raj, Jeffrey Pradeep, Pinto, Reevan Winston, Tomy, Suraj Kallarakal, Kulkarni, Shruthi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121724/ https://www.ncbi.nlm.nih.gov/pubmed/35603105 http://dx.doi.org/10.4103/ijn.IJN_397_20 |
Ejemplares similares
-
The effect of proton pump inhibitors on glycaemic control in diabetic patients
por: Rajput, Muhammad Ali, et al.
Publicado: (2020) -
Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023) -
Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008) -
Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016) -
Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)